Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CCL22 mRNA] | decreases expression|decreases reaction | 19350554
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of CCL22 mRNA | decreases expression | 15282401
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CCL22 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
CCL22 mRNA results in decreased susceptibility to Arsenic | decreases response to substance | 17976673
|
C006632 |
arsenic trioxide |
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CCL22 mRNA] | decreases expression|decreases reaction | 19350554
|
C006632 |
arsenic trioxide |
[arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL22 mRNA | affects cotreatment|increases expression | 19828696
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of CCL22 mRNA | decreases expression | 19128835 19350554
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of CCL22 protein | increases expression | 17719030
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CCL22 mRNA | increases expression | 18035473
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CCL22 mRNA | affects cotreatment|increases expression | 17183730
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides promotes the reaction [Shiga Toxin 2 results in increased secretion of CCL22 protein] | increases reaction|increases secretion | 16366002
|
D015232 |
Dinoprostone |
Dinoprostone results in increased expression of CCL22 mRNA | increases expression | 16303787
|
D022641 |
Shiga Toxin 2 |
Lipopolysaccharides promotes the reaction [Shiga Toxin 2 results in increased secretion of CCL22 protein] | increases reaction|increases secretion | 16366002
|
D022641 |
Shiga Toxin 2 |
Shiga Toxin 2 results in increased secretion of CCL22 protein | increases secretion | 16366002
|
D012906 |
Smoke |
Smoke results in increased secretion of CCL22 protein | increases secretion | 17041012
|
D014212 |
Tretinoin |
[arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL22 mRNA | affects cotreatment|increases expression | 19828696
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CCL22 mRNA | increases expression | 19828696
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CCL22 protein | increases expression | 19828696
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CCL22 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.57 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.98 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.09 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.72 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
4.72 | 16033868 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
3.58 | 19555203 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
5.08 | 17942926 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.31 | 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.62 | 17497229 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.67 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
5.70 | 10388637 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.88 | 12569548 16835338 18414634 16251483 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.11 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.28 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 18558336 17688650 18316065 19460635 18985861 19232924 15238991 18396377 18775368 18940202 16609825 17507914 18177632 17157402 20603192 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.81 | 15976003 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.10 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.35 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.35 | 16197459 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.43 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.27 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.39 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
4.06 | 19555203 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.62 | 17687452 15504454 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.72 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.72 | 16217749 14691202 15553829 11135700 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.72 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.97 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.17 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
11.02 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
11.02 | 17687452 15504454 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
11.02 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
11.02 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.13 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.48 | 15738583 19152805 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.36 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
7.72 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
7.72 | 16192471 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.69 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.25 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.87 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.87 | 9664655 16925845 8800419 9211117 14991402 9224671 10589399 9142499 9125849 17551590 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.87 | 17688650 16575769 8888407 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.42 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
marker/mechanism |
|
| 18249437 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.61 | 11488427 7237001 10446763 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
6.60 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
6.60 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.60 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.11 | 1851702 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.56 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.14 | 16569247 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.48 | 17637181 15328337 15821434 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.23 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.01 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.96 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.63 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.37 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.15 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.81 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
4.81 | 17016578 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.62 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.10 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.10 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.98 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.19 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Dinoprostone |
9.80 | 11852909 16997862 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
9.80 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.58 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.66 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.33 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.04 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.22 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.92 | 9664655 14991402 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
11.46 | 16366002 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Shiga Toxin 2 |
11.46 | 16366002 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.95 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
8.44 | 16793879 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.44 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.51 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
2.89 | 9931084 11953799 16076760 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.70 | 16612254 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.66 | 16093927 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.46 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.46 | 12878042 17255318 9205823 17963957 17237260 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.69 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.95 | 17551590 15992940 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.07 | 12749816 16930632 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.43 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.43 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.85 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.39 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.47 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.66 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.66 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
6.18 | 16467208 17050201 19850784 16968895 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.18 | 16294345 17596541 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
6.18 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
12.98 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
12.98 | 12018890 17217047 15748426 12679006 9834237 16330433 15336539 15622746 17107899 17869043 16331271 15213294 12712474 19075265 17712046 11468182 19035177 11161223 17649720 16891316 16966277 16112521 19642359 16823087 19225113 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
12.98 | 17217047 9834237 19035177 17506722 19642359 12679006 17368321 17294898 17339181 16823087 17107899 17712046 19029980 16788101 17301526 17361223 16331271 16891316 15748426 19075265 16935935 17649720 19225113 16766008 16140955 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.42 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.78 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
5.15 | 15723089 18095165 18629640 17196135 15138612 16270385 16603200 17719030 17881167 12925901 15744066 15081153 15793283 18364076 17203207 16544323 15591649 18237412 16570917 15298665 17534399 15763062 14659978 15086199 18210741 17432682 15504291 14709902 17348192 15842777 16009107 12918455 17201889 17640959 18239293 15733078 16627068 15099470 15798949 15366600 15383259 18371158 17465448 17036385 18567088 17666798 16042886 15492853 15571005 15339415 14643895 15942678 15369754 15577212 15161499 15864749 17724770 18672772 14568256 18637143 17198567 15067225 15479170 16169303 14726149 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
5.15 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.15 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
5.15 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
4.78 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
4.78 | 15816358 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
4.46 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
7.74 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.74 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
7.74 | 3113478 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.36 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
6.36 | 15603536 6150874 1848544 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.39 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
4.09 | 12815614 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.36 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.08 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
5.06 | 17306315 17976673 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
5.06 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
5.06 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Smoke |
5.06 | 11091918 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.95 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.23 | 18765137 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
5.33 | 11304026 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.14 | 19417148 15949261 14977855 11468182 19549372 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.08 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.77 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
12.48 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
12.48 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
12.48 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.03 | 15371236 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.02 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
3.60 | 14720322 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.43 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.84 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
23.16 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
23.16 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
23.16 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
23.16 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
23.16 | 8888407 16359493 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.43 | 17056641 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
6.57 | 18500342 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
8.04 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
8.04 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.04 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.35 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.35 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.22 | 19927285 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.24 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.07 | 15371236 6392382 16905509 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.64 | 11605937 12224865 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.91 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.40 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.40 | 19131511 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
9.48 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
9.48 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.64 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.58 | 12210543 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.76 | 10835634 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.06 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
11.06 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.02 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.77 | 16876388 15475178 14763951 1511512 11044598 17978042 11738929 3137016 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.76 | 17938729 17548696 17453740 18709164 19834688 16702368 17050553 16759981 16353154 6392382 15952646 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
5.99 | 15504454 17050553 19538983 17029826 17976673 16251483 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.99 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.82 | 19490988 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.37 | 12587719 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.64 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.49 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
3.49 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.49 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
4.05 | 17918041 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.21 | 15821434 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.35 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.35 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.04 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.33 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.60 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.34 | 17976673 11144890 19429237 17306315 15987713 19322015 18640142 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.34 | 20435036 11780464 12845720 12973940 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.71 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.73 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.71 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.82 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |